An infant with anomalous origin of the left coronary artery from the pulmonary artery is presented, and the problem of the direction of blood flow in the anomalous vessel is discussed. Determinations ...

Perinatal/Neonatal Case Presentation Published: 29 April 2013 Perinatal/Neonatal Case Presentation Prenatal diagnosis of Potocki–Lupski syndrome in a fetus with hypoplastic left heart and ...

Anatomy The left subclavian artery originates as the third branch from the transverse region of the aorta, following the brachiocephalic trunk and the left common carotid artery. The subclavian ...

Expert Rev Cardiovasc Ther. 2010;8(9):1275-1282. Finally, we examined our own experience with a 9-year follow-up of primary stenting, which is one of the longest to date. A total of 91 patients ...

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and limb events and mortality, researchers reported at the Society for ...

Background A substantial body of evidence demonstrates that myocardial revascularisation using bilateral internal mammary arteries (BIMA) improves long-term survival compared with single/left internal ...

June 18, 2025—Anaconda Biomed, SL, announced that it has received CE Mark certification for its ANA5 advanced neurovascular access funnel catheter. The CE Mark enables eventual commercial availability ...

Anatomo-physiological conditions such as left-right shunt (increases flow to the pulmonary artery), systemic vascular resistance and PDA contributed to the longevity of the patient in question into ...

Nasser et al. reported a very interesting case of an 82-year-old asymptomatic female with an aberrant right subclavian artery (ARSA) which was treated clinically. 1 In fact, according to recent ...

Objective To improve early diagnosis of patients who have basilar artery occlusion (BAO) and to provide evidence for treatment decisions based on clinical characteristics, treatment strategies, and ...

June 5, 2025—Penumbra, Inc. announced the FDA clearance and launch of the Ruby XL system, part of the company’s Ruby portfolio of peripheral embolization products. According to Penumbra, the Ruby XL, ...